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SpleenOur laboratory has previously demonstrated the presence of constitutively expressed mitochondrial
uncoupling protein 1 in mouse thymocytes. In our endeavours to understand the role of mitochondrial
uncoupling protein 1 in thymocyte function, we compared cell proﬁles in thymus and spleen of wild-type
with those of UCP 1 knock-out mice, which in turn led to comparative investigations of apoptotic potential in
thymocytes from these mice. We demonstrate that spleen cell numbers were reduced ∼3-fold in UCP 1
knock-out mice compared to wild-type mice. We record a halving of CD8 single positive cell numbers in
thymus with a signiﬁcant incremental increase in CD4/CD8 double positives cell numbers in the thymus of
UCP 1 knock-out mice compared to wild-type mice. These data are mirrored by an approximate halving of
CD8 single positive cell numbers and a doubling of CD4/CD8 double positive cell numbers in the spleen of
UCP 1 knock-out mice compared to wild-type mice. These differences are most probably explained by our
observations of decreased apoptotic potential and higher ATP levels in thymocytes of UCP 1 knock-out mice
when compared to wild-type controls. We conclude that constitutively expressed UCP 1 is a factor in
determining T-cell population selection in mice.ne serum albumin; DP, CD4+/
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The thymus is a primary lymphoid tissue where progenitor
thymocytes from bone marrow develop into mature thymocytes and
via antigen selectionprocessesdevelop tonaïve T-cellswhichmigrate to
peripheral lymphoid tissue, such as spleen and lymph nodes [for
reviews see 1–3] . Thus the thymus contains thymocytes that are at
different stages of maturation. The most immature of these cells are
easily identiﬁed due to the lack of the CD4/CD8 surface antigens (CD4/
CD8 double negatives DN)) and account for up to ∼5% of the cells
present in the thymus. Progress tomaturation can be followed ﬁrstly by
the expression of both CD4 and CD8 antigens on the thymocyte surface
(CD4/CD8double positives (DP)),which account for up to 85%of cells in
the thymus. The DP cells undergo positive selection for antigen and
negative selection for self-antigen resulting in attrition of up to 95% of
these cells through apoptosis. The remaining 5% of selected DP cells
generate either naïve CD4 single positive (CD4 SP) or naïve CD8 single
positive (CD8 SP) cells which enter the medulla of the thymus before
they migrate to the peripheral immune tissues. In a peripheral immunetissue such as the spleen, CD4 SP T-cells account for approximately 20%
of all cells, CD8 SP T-cells account for approximately 10% of all cells,
whereas the amount of CD4/CD8 DP T-cells is negligible [4]. The
remainder of the cells in the spleen are composed mainly of
reticulocytes, monocytes and B-lymphocytes [5]. For many apoptotic
events the Bcl-2 family of mitochondrial proteins play a central role [6].
For instance, Bim, a BH3-only Bcl-2 family member, is required for
apoptosis of thymocytes in response to negative selection [7].
Furthermore, there is a hierarchy of ATP usage in thymocytes [8] and
although ATP is necessary for apoptosis [9], low intracellular ATP levels
can trigger nitric oxide induced apoptosis [10].
Until relatively recently, mitochondrial uncoupling protein 1 (UCP
1) had only ever been associated with mitochondria of brown adipose
tissue. Under conditions of cold-stress, brown adipose tissue UCP 1
activity results in uncoupling of mitochondrial ATP synthesis, from
oxygen consumption, by dissipating the proton electrochemical
gradient, generated by the electron transport chain across the inner
membrane. The resulting increased metabolic ﬂux, increased heat
production by brown adipose tissue and ultimately distribution of
that heat throughout the whole body, is a process termed non-
shivering thermogenesis [11–13]. UCP 1 has also, however, been
shown to be present in thymocyte mitochondria, and although the
original empirical evidence had been contested [14], the recent cell
imaging evidence demonstrating UCP 1 present in thymocytes from
wild-type mice but absent in thymocytes from UCP 1 knock-out mice,
has proven very convincing [15–18]. Interestingly, despite the fact
that T-cells in the spleen are derived from the thymus, no transcripts
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indication of a role for UCP 1 in thymus function, but we had
established that UCP1 did not have a thermogenic role in thymus, as
cold-acclimation did not result in increased UCP 1 expression there
[20]. In this study we investigated whether the absence of UCP 1 in
thymocytes resulted in a difference in thymus and spleen cell
composition proﬁle and function when compared to wild-type mice
of the same background, sex, age and strain.
2. Materials and methods
2.1. Reagents
All reagents and chemicals used were of analytical grade where
possible and were obtained from Sigma Chemical Co. Ltd, Fancy Rd.,
Poole, Dorset, U.K. unless otherwise stated.
2.2. Animal source
UCP 1 knock-out mice on a C57BL/6J background, originally
provided by Dr Leslie Kozak (Pennington Biomedical Research Center,
Baton Rouge, Louisiana, US) andwild-type C57BL/6J backgroundmice
were bred in-house. The background of the UCP 1 knock-out mice is
essentially congenic with C57 [21]. UCP 1 knock-out mice were
conﬁrmed to be homozygous by PCR genotyping of tail DNA. All
animals had access to food andwater ad libitum. All animalswere kept
at room temperature. Only 3 week old female C57BL/6J wild-type and
3 week old female UCP 1 knock-out mice were used in this study.
2.3. Thymocyte isolation
Thymocytes were isolated from UCP-1 knock-out/wild-type
C57BL/6 mice essentially as described by Buttgereit and Brand [8].
The thymus was removed, trimmed clean of connective tissue and
brown fat (if present) and transferred into Hanks' Balanced Salt
Solution (Sigma) containing 10% (w/v) fetal bovine serum (FBS). A
single cell suspensionwas prepared by passage through a 70 μmnylon
sieve (Falcon).
2.4. Indirect immunoﬂuorescence
Isolated thymocytes were prepared for indirect immunoﬂuores-
cence essentially as described in Adams et al. [17]. Thymocytes were
suspended in Hanks medium (and 10% FBS). 0.5% (v/v) paraformal-
dehyde was added to 1 ml of thymocytes and incubated on ice for
5 min. 20 μl of cells were added to the slides (poly-l-lysine coated)
and allowed to dry (phosphate crystals form). Slides were then
dipped in methanol at −20 °C for 5 min. Slides were then dipped in
acetone at−20 °C for 5 min. Slides were then allowed to dry at room
temperature.
The cells on the cover-slips were then incubated with blocking
buffer (PBS containing 5% (w/v) BSA and methylamine, 0.1 M) for 2 h
at room temperature in petri dishes, to inactivate any remaining
formaldehyde and block non-speciﬁc binding. The cells on the cover-
slips were incubated with primary antibody diluted in PBS containing
5% (w/v) BSA overnight at room temperature. Following washing
with PBS the cells on the cover-slips were incubated with the
secondary antibody conjugated to a ﬂuor diluted with PBS for 3 h at
room temperature. The cells on the cover-slips were then washed
with PBS (and sodium azide) and ﬁnally mounted onto glass slides
using 5 µl of anti-quench solution.
2.5. Preparation of anti-quench
The anti-oxidant n-propyl gallate (4%, v/v) was dissolved in PBS
buffer containing sodium azide (15 mM) and glycerol (50%, w/v). Thissolution was always made fresh on the day and stored at 4 °C in the
dark until required.
2.6. Confocal microscopy
Confocal microscopy was performed essentially as described by
Adams et al. [17]. The 12 well plates with anti-quench solution were
covered with cover-slips and were afﬁxed to the glass slide by
applying a thin ﬁlm of nail varnish to the edges of the cover-slip. This
procedure also prevented the samples from drying out. The slides
were examined by phase contrast and confocal microscopy with an
Olympus Fluoview FV1000 Imaging system. The excitation light for
imaging was provided by the 457–514 nm lines of a multi-line Argon
laser, the 543 nm line of a green Helium–Neon laser and the 633 nm
line of a red Helium–Neon laser. Images were collected and processed
with the Olympus Fluoview software (version 1.3c). Thymocytes were
probed with FITC-conjugated anti-CD4, R-PE-conjugated anti-CD8
(both from BD Biosciences) and UCP 1 antibody (Calbiochem) using
Alexa 647 labelled secondary antibody (Invitrogen-magenta).
2.7. Flow cytometry — cell detection
Thymocytes/splenocytes were washed and adjusted to 5×106/ml
in PBSA (1%BSA-PBS, w/v) and 50 µl was used for each sample. Cells
were incubated on ice for 15 min in the dark with the surface staining
antibodies (CD4-FITC and CD8-R-PE). Fixation medium (Caltag A;
Invitrogen) was added to each tube, followed by incubation on ice for
15 min. Cells were washed twice in PBSA, followed by resuspension in
permeabilization medium (Caltag B; Invitrogen) and anti-UCP 1 for
15 min on ice in the dark. Cells were washed twice in PBSA and
resuspended in Caltag B and Alexa 647 labelled secondary antibody
and incubated on ice for 15 min. Cells were washed twice and 30,000
events collected on a DakoCyan ADP ﬂow cytometer. Data was
analyzed using Flowjo software.
2.8. Thymocyte incubations with dexamethasone
Thymocytes were seeded in RPMI-1640 medium supplemented
with 10% heat-inactivated fetal bovine serum, 2 mM glutamine,
penicillin (100 U/ml) and streptomycin (100 μg/ml) in the presence
or absence (just vehicle, ethanol) of 0.1 μM dexamethasone for up
to 18 h in a 37 °C humidiﬁed incubator under an atmosphere of 5%
CO2.
2.9. Isolation of bone marrow and spleen cell mitochondria
All bonemarrow and spleen cell homogenate, red cells, monocytes
and lymphocytes fractions were centrifuged at 300×g for 5 min at
4 °C. The supernatants were discarded and all cellular fractions were
resuspended in ice-cold (0–4 °C) STE buffer (250 mM Sucrose, 5 mM
Tris–HCl, 2 mM EGTA, pH 7.4). Mitochondria were isolated according
to the protocol of Chappell and Hansford [22].
2.10. Mitochondrial protein determination using the Markwell assay
Mitochondrial protein concentration was determined by the
reduction of Folins–Ciocalteau phosphomolybdic–phosphotungstic
reagent according to the method of Markwell et al. [23].
2.11. SDS-PAGE and Western blot analysis
One-dimensional SDS-PAGE under reducing conditions was used to
separate proteins prior to immunoblot analysis, as described by
Cunningham et al. [24] Following SDS-PAGE, resolved proteins were
transferred onto polyvinylidene diﬂuoridemembranes (Immobilin-PSQ;
Millipore) as described by Cunninghamet al. [24]. Commercial anti-UCP
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pyruvate dehydrogenase (PDH) E1α monoclonal antibody was from
MitoSciences. The primary antibodies were all used at 1:1000 dilution.
Following blocking and overnight primary antibody incubation, the
blots were incubated with a horseradish peroxidase-conjugated goat
anti-rabbit secondary antibody (1:10,000) in Tris-buffered saline (TBS),
0.5% (v/v) Tween 20, 5% (w/v) bovine serum albumin for 1 h at room
temperature. Blots were developed using an ECL detection system
(Amersham Biosciences), and immunoreactions were visualized by
exposure to Kodak X-Omat LS ﬁlm.
2.12. Densitometry
FollowingWestern blot analysis, the relative abundance of protein
was determined using densitometry. The band intensities of the
exposed ﬁlm were analyzed using Scion Imaging Software.
2.13. Flow cytometry FITC-annexin V/propidium iodide (PI) staining
The apoptosis of isolated thymocytes treatedwith dexamethasone,
was examined. To determine early membrane and DNA changes,
whole thymocytes were stained with FITC-conjugated Annexin V and
propidium iodide (PI) according to manufacturer's instructions
(Molecular Probes). Cells (0.75×106) were suspended in 100 μl of
annexin-binding buffer, and 5 μl of FITC-annexin V and 1 μl of PI
(100 μg/ml) was added to each 100 μl cell suspension. Cells were
incubated for 15 min at room temperature. Stained cells were
suspended in 400 μl of binding buffer and immediately processed by
ﬂow cytometry.
2.14. Caspase 3/7 activity
The Caspase-Glo 3/7 Assay (Promega) is a luminescent assay that
measures caspase 3 and caspase 7 activities in suspension cells. This
assay provides a proluminescent caspase μ3/7 substrate, whichFig. 1. UCP 1 protein expression in mitochondria from thymi of mice. Mitochondria (10 μg) fr
to SDS-PAGE andWestern blotting using (A) a 1:1000 dilution of an anti-UCP 1 peptide antibo
brown fat, bone marrow, thymus, spleen and liver were isolated and subjected to SDS-PAG
(Sigma) and (D) PDH peptide antibody (Cambridge Biosciences).contains the tetrapeptide sequence DEVD. The substrate is cleaved
to release aminoluciferin, a substrate of luciferase used in the
production of light. The addition of the single Caspase-Glo 3/7 reagent
results in cell lysis, followed by caspase cleavage of the substrate and
generation of a luminescent signal. Thymocytes from UCP 1−/−mice
and C57BL/6 mice were isolated and induced into apoptosis with
either (a) 0.1 μM dexamethasone, (b) vehicle alone (ethanol) or (c)
no addition (untreated control) at 37 °C in a 5% (v/v) CO2
environment. After 5 h, cells were resuspended at 2×106/ml in
RPMI-1640. 100 μl of Caspase-Glo 3/7 reagent was added to each well
of a white walled 96-well plate containing 100 μl of control or drug
treated thymocytes in RPMI-1640. Contents of the wells were gently
mixed on a plate shaker for 30 s, and incubated at room temperature
for 1 h. The luminescence of each well was measured on a plate
reading luminometer.
2.15. DNA fragmentation
DNA electrophoresis was performed using 107 thymocytes
incubated at 37 °C in medium containing ethanol (vehicle) or
0.1 µM dexamethasone-supplemented medium. Cells were harvested
and resuspended in 1 ml cell lysis buffer (20 mM EDTA, 100 mM Tris
pH 8.0 0.8% (w/v) sodium lauryl sarcosinate) and incubated at 37 °C
for 1 h. 0.5 mg/ml RNAse was then added to each sample and left for a
further 2 h at 37 °C. Finally the samples were treated with 6 mg/ml
proteinase K and were left overnight at 37 °C. An aliquot of each
sample (45 µl) was mixed with 5 µl DNA loading dye and resolved
on a 1% agarose gel in 0.4 M Tris-acetate, 0.01 M EDTA, pH 8.3 (TAE),
pre-stained with ethidium bromide. DNA was electrophoresed at a
constant voltage of 55 V for 2 h 30 min.
2.16. Measurement of ATP levels
The ApoSENSOR ADP/ATP ratio assay kit (BioVision) utilizes the
enzyme luciferase to catalyze the formation of light from ATP andom thymus were isolated from 1, 2, 3, 4, 5, 6, 8 and 16 week old C57bl/6 mice, subjected
dy (Sigma) and (B) PDH peptide antibody (Cambridge Biosciences). Mitochondria from
E and Western blotting using (C) a 1:1000 dilution of an anti-UCP 1 peptide antibody
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Thymocytes from UCP 1−/− mice and C57BL/6 mice were isolated
and resuspended at 1×106 in PBS. Triplicate cell samples (10 μl per
well) were placed in a white walled 96 well luminometer plate.
Nucleotide releasing buffer was then added to each well (100 μl), to
lyse the cells, and left at room temperature for 5 min. To measure the
ATP levels in the thymocytes fromUCP 1−/−mice and C57BL/6mice,
1 μl of the ATP monitoring enzyme was added to the resulting lysates.
The resulting luminescence was measured 1 min later.2.17. Measurement of oxygen consumption rates of cells
All measurements of respiration were made using an Oxygraph-2k
respirometer (Oroboros Instruments, Innsbrück, Austria), and oxygen
ﬂux was resolved using DATLAB software. The oxygraph-2k is a two
chamber titration–injection respirometer with a limit of oxygen ﬂux
detection of 1 pmol/ml−1. Standardized instrumental and chemical
calibrationswere performed to correct for back diffusion of oxygen into
the chamber from the various components; leak from the exterior,Fig. 2. Characterization of thymocytes isolated from wild-type C57BL/6 mice. A. Representa
mice. Numbers in the dot plot represent percentage of cells in each quadrant using 10,000 ce
(both from BD Biosciences) B. All thymocytes were simultaneously labelled for mitochondri
expressed as a percentage. Each thymocyte subset was deﬁned by the number of cells in each
graph shows the FACS Proﬁles for UCP 1 in CD4/CD8 double positive (DP) thymocytes (blu
thymocytes (red) and CD8 single positive (CD8 SP) thymocytes (yellow). UCP 1 was d
(Invitrogen-magenta). The intensity of ﬂuorescence due to non-speciﬁc binding by the se
thymocytes were ﬁxed and permeabilized as described in the Materials and methods sectio
anti-CD8 (red) [both from BD Biosciences] and UCP 1 antibody (Calbiochem) using Alexa 6oxygen consumption by the chemical medium, and sensor oxygen
consumption. The cell suspension was stirred using a PDVF magnetic
stirrer and thermostatically maintained at 28 °C. Before each experi-
ment mediumwas equilibrated for 30–40 min with air in the oxygraph
chambers until a stable signal was achieved to calibrate for oxygen
saturation. Quiescent thymocyte steady-state oxygen consumption
rates were then measured in RPMI medium (5×106 cells/ml).3. Results
Three week old mice were selected for this study based on the
observation that UCP 1 expression in mitochondria from thymi of
wild-type mice was persistently evident in mice of less than 5 weeks
old (Fig. 1A and B). We also conﬁrm previously reported RT-PCR
evidence that UCP 1 protein is only evident in mitochondria from
thymus and not in mitochondria from bone marrow or spleen cells
(Fig. 1C and D).
Fig. 2A give a typical proﬁle of the thymocyte cells present in the
thymus of mouse, indicating, as expected, that themajority of cells aretive two colour ﬂow cytometry analysis of thymocyte subsets from wild-type C57BL/6
lls. Thymocytes were probed with FITC-conjugated anti-CD4, R-PE-conjugated anti-CD8
al UCP1, and a proﬁle of the proportion of each thymocyte subset containing UCP 1 was
quadrant. Intensity of ﬂuorescence is proportional to the amount of UCP 1 present. The
e), CD4/CD8 double negative (DN) thymocytes (green), CD4 single positive (CD4 SP)
etected with anti-UCP 1 antibody (Calbiochem) and secondary Alexa-647 antibody
condary antibody (negative control) is depicted by the grey lined proﬁle. C. Isolated
n. Thymocytes were probed with FITC-conjugated anti-CD4 (green), R-PE-conjugated
47 labelled secondary antibody (Invitrogen-magenta)(4200 zoom; Bar 5 µm).
Table 1
Thymus and spleen mass in C57BL/6 wild-type and UCP 1 knock-out mice.
Animal source/tissue Thymus (grams) Spleen (grams)
Wild-type mice 0.073±0.006(9) 0.073±0.009(9)
UCP 1 KO mice 0.087±0.009(9) 0.067±0.006(9)
Data represents the mean±SEM of 9 separate measurements. p values≤0.05 on an
unpaired Student's ‘t’-test were deemed signiﬁcant. No signiﬁcant difference was
observed in a comparison of tissue mass between C57BL/6 wild-type and UCP 1 knock-
out mice.
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UCP 1 is associated with all thymocyte cell types: CD4/CD8 double
positive (DP) thymocytes, CD4/CD8 double negative (DN) thymo-
cytes, CD4 single positive (CD4 SP) thymocytes and CD8 single
positive (CD8 SP) thymocytes. The association of UCP 1 with CD4/CD8
double positive (DP) thymocytes is visually demonstrated in the
confocal images in Fig. 2C.
In light of the observation that mitochondrial uncoupling protein 1
(UCP 1) is present in thymocytes (but not spleen) of mouse, and
because the T-cell proﬁle of the spleen is contributed to by the
thymus, we compared a variety of tissue and cell parameters from
both thymus and spleen from C57BL/6 wild-type and UCP 1 knock-
out mice, to ascertain whether there were differences in cell proﬁle
and function. Table 1 holds data for thymus and spleen tissue masses
from C57BL/6 wild-type and UCP 1 knock-out mice. No signiﬁcant
difference was observed in a comparison of tissue mass from C57BL/6
wild-type and UCP 1 knock-out mice, however there is a trend for the
spleen mass of knock-out mice to be lower than that from wild-type
mice.
Despite the fact that we saw no signiﬁcant difference in thymus or
spleen tissue mass in a comparison of C57BL/6 wild-type and UCP 1
knock-out mice (Table 1), we nevertheless performed a cell count
from these tissues. We observed no difference in cell numbers in a
comparison of the thymus from C57BL/6 wild-type and UCP 1 knock-
out mice (Fig. 3A), but we did observe a signiﬁcant ∼3-fold decrease
in cell number in a comparison of the spleen cell number from C57BL/
6 wild-type and UCP 1 knock-out mice (Fig. 3B).Fig. 3. Number of cells per thymus and spleen from 3 week old wild-type C57BL/6 and
UCP 1−/−mice. The bar chart depicts the collated data for cell number for (A) thymus
and (B) spleenofwild-type (■) andUCP1knock-out (□)mice. Data are from three separate
experiments each performed in at least triplicate (mean±SEM (3)). p values≤0.05 on an
unpaired Student's ‘t’-test were deemed signiﬁcant.Furthermore, we proﬁled the cells within the thymus (Fig. 4A–F)
and compared those from C57BL/6 wild-type and UCP 1 knock-out
mice. Fig. 4A and B are typical examples of the primary FACS analysis
data for mouse thymus. From our collated data we were able to
demonstrate a signiﬁcant ∼2-fold decrease in the CD8 single positive
cells (Fig. 4C) and a signiﬁcant ∼10% increase in CD8/CD4 double
positive cells (Fig. 4D) from UCP 1 knock-out mice when compared to
thymocytes from C57BL/6 wild-type mice. No signiﬁcant difference
was observed in the proportion of CD8/CD4 double negative or CD4
single positive thymocytes isolated from C57BL/6 wild-type mice
compared to UCP 1 knock-out mice (Fig. 4E and F).
As there is a signiﬁcant contribution to T-cells in the spleen from
the thymus, we identiﬁed and determined the relative abundance of
CD8 single positive, CD4 single positive and CD8/CD4 double positive
cells within the spleen (Fig. 5A–F) and compared those from C57BL/6
wild-type and UCP 1 knock-out mice. An example of the FACS analysis
primary data for mouse spleen is given in Fig. 5A and B.We observed a
signiﬁcant ∼2-fold decrease in the CD8 single positive cells (Fig. 5C)
and a signiﬁcant ∼2-fold increase in CD8/CD4 double positive T-cells
(Fig. 5D) in the spleen of UCP 1 knock-out mice compared to cells
from C57BL/6 wild-type mice. No signiﬁcant difference was observed
in the proportion of other cells (which includes CD8/CD4 double
negative T-cells) (Fig. 5C) or CD4 single positive T-cells (Fig. 5D)
isolated from C57BL/6 wild-type compared to UCP 1 knock-out mice.
The decrease in the proportion of CD8 single positive thymocytes
in the thymus (Fig. 4C) and CD8 single positive T-cells in the spleen
(Fig. 5C), together with the increase in CD8/CD4 double positive
thymocytes in the thymus (Fig. 4D) and the doubling of CD8/CD4
double positive circulating T-cells (Fig. 5D) led us to questionwhether
there was a differential effect in apoptotic potential in a comparison of
thymocytes from C57BL/6 wild-type and UCP 1 knock-out mice. Fig. 6
contains primary data and collated data for annexin V plasma
membrane phosphatidylserine binding and propidium iodide DNA
staining, as measures of the extent of apoptosis, after 5 h (Fig. 6 A, B
and C) and 18 h (Fig. 6 D, E and F) for dexamethasone and vehicle-
treated thymocytes from C57BL/6 wild-type and UCP 1 knock-out
mice. Our data show no signiﬁcant difference in apoptotic potential in
a comparison of dexamethasone-treated thymocytes (uncorrected for
vehicle) from C57BL/6 wild-type and UCP 1 knock-out mice after 5 h
(Fig. 6C) and no signiﬁcant difference in apoptotic potential in a
comparison of dexamethasone-treated thymocytes (uncorrected for
vehicle) from C57BL/6 wild-type and UCP 1 knock-out mice after 18 h
(Fig. 6F). However there is a signiﬁcant decrease in apoptotic potential
in vehicle-treated thymocytes from UCP 1 knock-out mice after 5 h
compared to cells from wild-type mice (Fig. 6C) and a signiﬁcant
decrease in apoptotic potential in vehicle-treated thymocytes from
UCP 1 knock-out mice after 18 h when compared to thymocytes from
C57BL/6 wild-type mice (Fig. 6F).
An additional index of apoptosis, namely caspase 3 and 7 activity
in dexamethasone-treated, vehicle-treated and untreated control
thymocytes from C57BL/6 wild-type and UCP 1 knock-out mice,
indicated less caspase activity in thymocytes from UCP 1 knock-out
mice for dexamethasone-treated, vehicle-treated and untreated
control thymocytes (Fig. 7). These data, depicting caspase activity in
Fig. 7, are consistent with the independent indices of apoptosis,
namely annexin V binding and propidium iodide staining laid out in
Fig. 6.
The former data in Figs. 6 and 7 are further endorsed by our
observation of increased DNA laddering in dexamethasone-treated
and control thymocytes from C57BL/6 wild-type mice compared to
UCP 1 knock-out mice (Fig. 8).
The decreased apoptotic potential of thymocytes from UCP 1
knock-out mice when compared to thymocytes from C57BL/6 wild-
typemice (Figs. 6–8) are consistent with our further observation of an
increased abundance of ATP in thymocytes from UCP 1 knock-out
mice when compared to thymocytes from C57BL/6 wild-type mice
Fig. 4. Cell subsets in thymus of 3 week old wild-type C57BL/6 and UCP 1−/− mice. Thymocytes from 3 week old wild-type C57BL/6 (■) and UCP 1 knock-out (□) mice were
isolated and the cells were stained for with FITC-conjugated anti-CD4, R-PE-conjugated anti-CD8 (both from BD Biosciences) and analyzed on the FACS Cyan. Representative dot
plots for thymocytes from (A) wild-type C57BL/6 and (B) UCP 1 knock-out mice are shown. Numbers represent percentage of total cells in each quadrant using 10,000 cells. The
percentage of cells that are (C) CD8 single positive (CD8 SP), (D) CD8/CD4 double positive (DP), (E) CD8 and CD4 double negative (DN) and (F) CD4 single positive (CD4 SP) are
indicated. Data are mean±SEM of six experiments performed in at least triplicate. p values≤0.05 on an unpaired Student's ‘t’-test were deemed signiﬁcant.
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UCP 1 on the total oxygen consumption rate by thymocytes (Fig. 9B).
4. Discussion
We have previously demonstrated empirically and using confocal
microscopy that thymocytes from mice have uncoupling protein 1
(UCP 1) associated with their mitochondria [15–18]. In light of this
observation we set out in this study to determine whether there was
any difference in thymus function by comparing proﬁles and function
of thymocytes from C57BL/6 wild-type and UCP 1 knock-out mice.
We ﬁrstly demonstrate that in our hands proﬁling of thymus from
C57BL/6 wild-type have UCP 1 prominently present for up to 5 weeks
(Fig. 1 A and B) and give a typical proﬁle to those in the literature [1]
with CD4/CD8 double positive cells being the predominant cell type
in the thymus (Fig. 2A). We also clearly demonstrate that mitochon-
drial UCP 1 is apparent in all thymocytes (Fig. 2B) with a clear
microscopic demonstration of UCP 1 in CD4/CD8 double positive cells
(Fig. 2C), but is not present in bone marrow (the site of thymocyte
progenitor cells) nor in spleen cells (a location for naive T-cells)
(Fig. 1B). Initial anatomical investigations gave no indication of anycellular phenotypic difference as there was no detectable difference in
mass of thymus and spleen from C57BL/6 wild-type and UCP 1 knock-
out mice (Table 1). However, when cell numbers from thymus and
spleen are compared, there is a signiﬁcant ∼3-fold reduction in cell
numbers in spleen, with no signiﬁcant difference in cell number in
thymus in a comparison of C57BL/6 wild-type and UCP 1 knock-out
mice (Fig. 3). Preliminary data from our laboratory indicate an
increase in cell size (results not shown) but further work is required
to cement this observation. Interpreting the data so far would suggest
that the absence of UCP 1 in thymus may affect cell number in spleen.
Analysis of the cell populations in a comparison of thymocytes
(Fig. 4) and spleens (Fig. 5) clearly demonstrates a signiﬁcant
incremental increase in CD4/CD8 double positives cells in the thymus
(Fig. 4) and a signiﬁcant doubling of CD4/CD8 double positives cells in
this peripheral tissue of UCP 1 knock-out mice compared to wild-type
mice (Fig. 5). We conclude from these data that there is either an
alteration in the positive or negative selection process in the thymus
so that CD4/CD8 double positive cells are in excess in the thymus and
spill over into the spleen.
In addition we observed a signiﬁcant halving of CD8 single positive
cells in the thymus (Fig. 4) concomitant with a signiﬁcant halving of
Fig. 5. Cell subsets in spleen of 3 week old wild-type C57BL/6 and UCP 1−/−mice. Spleen cells from 3 week old wild-type C57BL/6 (■) and UCP 1 knock-out (□) mice were isolated
and the cells were stained for with FITC-conjugated anti-CD4, R-PE-conjugated anti-CD8 (both from BD Biosciences) and analyzed on the FACS Cyan. Representative primary data for
spleen cell from (A) wild-type C57BL/6 and (B) UCP 1 knock-out mice are shown. Numbers represent percentage of total cells in each quadrant using 10,000 cells. The percentage of
T-cells that are (C) CD8 single positive (CD8 SP), (D) CD8/CD4 double positive (DP), (E) Other cells including CD8 and CD4 double negative (other cells) and (F) CD4 single positive
(CD4 SP) are indicated. Data are mean±SEM of six experiments performed in triplicate. p values≤0.05 on an unpaired Student's ‘t’-test were deemed signiﬁcant.
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changes in CD4 SP cells in the thymus when comparing cell proﬁle
from UCP 1 knock-out mice with those from wild-type mice. We
conclude from these data that the process of determining SP cell type
after negative selection is affected by the absence of UCP 1.
The high attrition rate of cells in the thymus, through positive and
negative selection by apoptosis, led us to investigate whether our
observations of decrease spleen cell numbers (Fig. 3) and the
decreased CD8 single positive and CD4/CD8 double positive cells in
the thymus and spleen of UCP I knock-out mice (Figs. 4 and 5), might
be due to differences in the apoptotic potential of thymocytes from
C57BL/6 wild-type and UCP 1 knock-out mice. Our data clearly
demonstrate that apoptotic potential is reduced in thymocytes from
UCP 1 knock-out mice which compared to C57BL/6 wild-type mice
(Figs. 6–8). Our interpretation from these data, in the context of the
Figs. 6–8, is that the reduced apoptotic potential of thymocytes from
UCP 1 knock-out mice probably explains (a) the halving of cell
numbers in spleen (b) the disrupted selection processes of CD4/CD8double positive cells and (c) the maturation of SP cell type following
negative selection.
In light of the fact that we have observed a signiﬁcant decrease in
spontaneous, non-dexamethasone-treated, apoptosis in thymocytes
from C57BL/6 wild-type mice compared to thymocytes from UCP 1
knock-out mice, and in light of the fact that steady-state UCP 1 activity
may reduce intracellular ATP status in thymocytes, we measured the
ATP levels in quiescent thymocytes from C57BL/6 wild-type and UCP 1
knock-out mice. Our observation that quiescent thymocytes from UCP
knock-out mice have higher ATP levels (Fig. 9A) is consistent with an
increased steady-statemitochondrial efﬁciency in thymocytes fromUCP
1 knock-outmice compared towild-type controls. Furthermore, in light
of the fact that nitric oxide mediated apoptosis in thymocytes is
dependent on efﬁcientmitochondria [25] and reduced intracellular ATP
levels trigger nitric oxide induced apoptosis [10], our observations of
higher intracellular ATP levels in cells of a lower apoptotic potential is
interesting and may hint at its mechanism. If we thus presume that the
higher ATP concentrations in thymocytes of UCP 1 knock-out mice are
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Fig. 7. Caspase activation in dexamethasone-treated, vehicle-treated and untreated (control) thymocytes from 3 week old C57BL/6wild-type andUCP 1−/−mice, as determined by the
Caspase-Glo 3/7 assay. Thymocytes fromwild-type C57BL/6 (■) andUCP 1 knock-out (□)micewere isolated and treatedwith either dexamethasone (0.1 µM), vehicle orwere untreated.
After 5 h, 104 cells were placed in each well and lysed. A substrate peptide for caspase 3 and 7 was added. Data are mean±SEM of three experiments performed in at least triplicate.
p values≤0.05 on an unpaired Student's ‘t’-test were deemed signiﬁcant.
Fig. 8. DNA fragmentation in untreated (control), vehicle-treated and dexamethasone
treated thymocytes from C57BL/6 wild-type and UCP 1−/− mice. The lanes on the
agarose gel show DNA markers and DNA isolated from untreated (0 h), vehicle-treated
(4 h) and dexamethasone-treated (4 h) thymocytes fromC57BL/6 (WT) andUCP 1−/−
(KO) mice.
Fig. 6. Percentage of apoptosis in vehicle-treated and dexamethasone-treated thymocytes fro
iodide (PI) staining. Thymocytes from wild-type C57BL/6 (■) and UCP 1 knock-out (□)m
(0.1 µM ) for 5 (A–C) and 18 (D–F) hours. Cells were collected and stained with Annexin
measurement were then collected on a FACS Cyan. Representative dot plots of dexamethaso
data for dexamethasone and vehicle-treated thymocytes after (5 h) (C) and 18 h (F) are
p values≤0.05 on an unpaired Student's ‘t’-test were deemed signiﬁcant.
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absence of UCP 1 increases the efﬁciency of the in situ mitochondria
resulting in the higher steady-state ATP concentration in knock-out
mice. Consequent to that, one might expect the proton leak in these
quiescent thymocytes of UCP 1 knock-outmice to be reduced compared
to thymocytes from wild-type mice which in turn might manifest itself
as a decrease in oxygen consumption at the whole cell (thymocyte)
oxygen consumption level. This was not apparent though, as there was
no signiﬁcantdifference in thewhole cell oxygen consumption rates in a
comparison of thymocytes from UCP 1 knock-out mice and from wild-
type mice (Fig. 9B). However, an equivalent observation was made by
Krauss et al. [26] who observed no signiﬁcant difference in the rate of
thymocyte oxygen consumption rates in a comparison of UCP2 knock-
out and wild-typemice, yet they didmanage to detect a difference in in
situ proton leak. Future work by us will explore whether in situ proton
leak is affected in thymocytes by the absence of UCP 1.
One could argue that the effects we observe on thymus and spleen
cell proﬁles, numbers and apoptotic potential may not in fact due to
absence of UCP 1 directly, but due to secondary effects on BAT function
in vivo. There is no doubt that brown fat has been reported to play a role
in the development of immune potential [27] and that the ablation of
UCP 1 can effect mitochondrial proton leak in skeletal muscle, a tissue
that does not contain UCP1 [28] . Such a metabolic inﬂuence, if it exists,
maywell explain differences in proﬁles andnumbersof the immediately
accessed thymus and spleen cells. However, it is probably less likely that
brown adipose tissue is affecting our observed apoptotic potential
differences in thymocytes, as in this instance we are working with
isolated cells, no longer under the inﬂuence of whatever regulation
might be imparted by brown adipose tissue.
Finally, the potential consequence of increased circulating DP
cells and reduced CD8SP T-cells in the UCP 1 knock-out mice
(compared to wild-type controls) are, on the face of it, quite similar,
in that CD8SP T-cells are anti-cancer and anti-viral whilst increasedm C57BL/6 wild-type and UCP 1−/−mice, as determined by annexin V and propidium
ice were isolated and treated with either the vehicle (VEH) or dexamethasone (DEX)
V (conjugated to Alexa 488— Millipore) and Propidium iodide (PI). 10,000 events per
ne-treated thymocytes after (5 h)(A and B) and 18 h (D and E) are indicated. Collated
indicated. Data are mean±SEM of four experiments performed in at least triplicate.
Fig. 9. Intracellular ATP levels and oxygen consumption rates of thymocytes from 3 week
old C57BL/6wild-type and UCP 1−/−mice. (A) ATP levels in quiescent thymocytes from
wild-type C57BL/6 (■) and UCP 1 knock-out (□) mice were determined using an
Aposensor ADP/ATP Ratio Assay Kit from Biovision. 10,000 cells were used for each
sample. (B) Cellular oxygen consumption rates of quiescent thymocytes was measured in
RPMImedium (5×106 cells/ml) using anOxygraphRespirometer (Oroboros Instruments,
Innsbrück, Austria). Data are mean±SEM of three experiments performed in at least
triplicate. p values≤0.05 on an unpaired Student's ‘t’-test were deemed signiﬁcant.
816 A.E. Adams et al. / Biochimica et Biophysica Acta 1797 (2010) 807–816circulating DP T-cells have been associatedwith increased cancers and
viral infection [4,29]. Thus extrapolating from our cell data to the
whole animal, one might expect UCP 1 knock-out mice to be more
susceptible to cancers and viral infection compared to wild-type
controls, however, I am not aware of any whole animal studies, as yet,
indicating such vulnerability, but in light our observations, future
investigations may highlight them.Acknowledgements
We thank Science Foundation Ireland for their Principal
Investigator grant to RKP (SFI06/IN.1/B67). RKP is a member of the
MITOFOOD COST action.References
[1] T.K. Starr, S.C. Jameson, K.A. Hogquist, Positive and negative selection of T cells,
Annu. Rev. Immunol. 21 (2003) 139–176.
[2] J.C. Zúñiga-Pﬂücker, T-cell development made easy, Nat. Rev., Immunol. 4 (2004)
67–72.
[3] A.C. Hayday, D.J. Pennington, Key factors in the organized chaos of early T-cell
development, Nat. Immunol. 8 (2007) 137–144.
[4] R.E. Mebius, G. Kraal, Structure and function of the spleen, Nat. Rev., Immunol. 5
(2005) 606–616.
[5] J.M. Adams, S. Cory, Life-or-death decisions by the Bcl-2 protein family, Trends
Biochem. Sci. 26 (2001) 61–66.
[6] K.H.G Mills, in: A. Robinson, G. Farrar, C. Wilbin (Eds.), Methods in Molecular
Medicine — Vaccine Protocols, Humana Press, New Jersey, 1996, pp. 197–221.
[7] P. Bouillet, J.F. Purton, D.I. Godfrey, L.C. Zhang, L. Coultas, H. Puthalakath, M.
Pellegrini, S. Cory, J.M. Adams, A. Strasser, BH3-only Bcl-2 family member Bim is
required for apoptosis of autoreactive thymocytes, Nature 415 (2002) 922–926.
[8] F. Buttgereit, M.D. Brand, A hierarchy of ATP-consuming processes in mammalian
cells, Biochem. J. 312 (1995) 163–167.
[9] C. Stefanelli, F. Bonavita, I. Stanic', G. Farruggia, E. Falcieri, I. Robuffo, C. Pignatti, C.
Muscari, C. Rossoni, C. Guarnieri, C.M. Caldarera, ATP depletion inhibits
glucocorticoid-induced thymocyte apoptosis, Biochem. J. 322 (1997) 909–917.
[10] K. Honda, K. Kato, N. Dairaku, K. Iijima, T. Koike, A. Imatani, H. Sekine, S. Ohara, H.
Matsui, T. Shimosegawa, High levels of intracellular ATP prevent nitric oxide-
induced apoptosis in rat gastric mucosal cell, Int. J. Exp. Path. 84 (2003) 281–288.
[11] D.G. Nicholls, R.M. Locke, Thermogenic mechanism in brown fat, Physiol. Rev. 64
(1984) 1–64.
[12] B. Cannon, J. Nedergaard, Brown adipose tissue: function and physiological
signiﬁcance, Physiol. Rev. 84 (2004) 277–359.
[13] D.G. Nicholls, The physiological regulation of uncoupling proteins, Biochim.
Biophys. Acta 1757 (2006) 459–466.
[14] A. Frontini, S. Rousset, A.M. Cassard-Doulcier, C. Zingaretti, D. Ricquier, S. Cinti,
Thymus uncoupling protein 1 is exclusive to typical brown adipocytes and is not
found in thymocytes, J. Histochem. Cytochem. 55 (2007) 183–189.
[15] A.M. Carroll, L.R. Haines, T.W. Pearson, C.M. Brennan, E.P. Breen, R.K. Porter,
ImmunodetectionofUCP1 in rat thymus, Biochem. Soc. Trans. 32 (2004) 1066–1067.
[16] A.M. Carroll, L.R. Haines, T.W. Pearson, P. Fallon, C. Walsh, C.M. Brennan, E.P.
Breen, R.K. Porter, Detection of a functioning UCP 1 in thymus, J. Biol. Chem. 280
(2005) 15534–15543.
[17] A.E. Adams, O. Hanrahan, D.N. Nolan, H.P. Voorheis, P. Fallon, R.K. Porter, Images of
mitochondrial UCP 1 in mouse thymocytes using confocal microscopy, Biochim.
Biophys. Acta 1777 (2007) 115–117.
[18] A.E. Adams, A.M. Carroll, P.G. Fallon, R.K. Porter, Mitochondrial uncoupling protein
1 expression in thymocytes, Biochim. Biophys. Acta 1777 (2008) 772–776.
[19] A.M. Carroll, R.K. Porter, Starvation-sensitive UCP 3 protein expression in thymus
and spleen mitochondria, Biochim Biophys Acta. 1700 (2004) 145–150.
[20] C.M. Brennan, E.P. Breen, R.K. Porter, Cold acclimation and oxygen consumption in
the thymus, Biochim. Biophys. Acta 1757 (2006) 1463–1468.
[21] W.E. Hofmann, X. Liu, C.M. Bearden, M.-E. Harper, L.P. Kozak, Effects of genetic
background on thermoregulation and fatty acid-induced uncoupling of mito-
chondria in UCP1-deﬁcient mice, J. Biol. Chem. 276 (2001) 12460–12465.
[22] J.B. Chappell, R.G. Hansford, in: G.D. Birnie (Ed.), Subcellular Components:
Preparation and Fractionation, Butterworths, London, 1972, pp. 77–91.
[23] M.A. Markwell, S.M. Haas, A modiﬁcation of the Lowry procedure to simplify
protein determination in membrane and lipoprotein samples, Anal. Biochem. 87
(1978) 206–210.
[24] O. Cunningham, A.M. McElligott, A.M. Carroll, E.P. Breen, C. Reguenga, M.E.M.
Oliveira, J.E. Azevedo, R.K. Porter, Selective detection of UCP 3 expression in
skeletal muscle: effect of thyroid status and temperature acclimation, Biochim.
Biophys. Acta 1604 (2003) 170–179.
[25] K. Migita, F. Tanaka, S. Abiru, H. Ida, Y. Izumi, A. Kawakami, K. Eguvhi, The role of
mitochondria innitric oxide-mediated thymocyte apoptosis, Immunol. Lett. 90 (2003)
87–91.
[26] S.Krauss, C.Y. Zhang, B.B. Lowell, A signiﬁcantportion ofmitochondrial proton leak in
intact thymocytes depends on expression of UCP2, Proc. Natl. Acad. Sci. U. S. A. 99
(2002) 118–122.
[27] B.D. Janković, Brown adipose tissue: its in vivo immunology and involvement in
neuroimmunomodulation, Ann. N.Y. Acad. Sci. 496 (2006) 3–26.
[28] S. Monemdjou, W.E. Hofmann, L.P. Kozak, M.-E. Harper, Increased mitochondrial
proton leak in skeletal muscle mitochondria of UCP1-deﬁcient mice, Am. J.
Physiol. Endocrinol. Metab. 279 (2000) E941–E946.
[29] M. Nascimbeni, E.C. Shin, L. Chiriboga, D.E. Kleiner, B. Rehermann, Peripheral CD4
(+)CD8(+) T cells are differentiated effector memory cells with antiviral
functions, Blood 104 (2004) 478–486.
